WO2017207931A1 - Dispositif formant catheter d'infusion pour traiter au moins une obstruction partielle ou totale dans un conduit, tel que conduit corporel - Google Patents
Dispositif formant catheter d'infusion pour traiter au moins une obstruction partielle ou totale dans un conduit, tel que conduit corporel Download PDFInfo
- Publication number
- WO2017207931A1 WO2017207931A1 PCT/FR2017/051368 FR2017051368W WO2017207931A1 WO 2017207931 A1 WO2017207931 A1 WO 2017207931A1 FR 2017051368 W FR2017051368 W FR 2017051368W WO 2017207931 A1 WO2017207931 A1 WO 2017207931A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- infusion
- catheter
- obstruction
- occlusion
- conduit
- Prior art date
Links
- 238000001802 infusion Methods 0.000 title claims abstract description 130
- 230000036961 partial effect Effects 0.000 title claims abstract description 47
- 239000003978 infusion fluid Substances 0.000 claims abstract description 91
- 239000007788 liquid Substances 0.000 claims abstract description 48
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 18
- 238000007789 sealing Methods 0.000 claims abstract description 6
- 210000004369 blood Anatomy 0.000 claims description 31
- 239000008280 blood Substances 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 30
- 210000001367 artery Anatomy 0.000 claims description 28
- 239000012530 fluid Substances 0.000 claims description 22
- 210000004351 coronary vessel Anatomy 0.000 claims description 19
- 239000003814 drug Substances 0.000 claims description 19
- 210000001635 urinary tract Anatomy 0.000 claims description 19
- 241001465754 Metazoa Species 0.000 claims description 17
- 210000004204 blood vessel Anatomy 0.000 claims description 16
- 210000003238 esophagus Anatomy 0.000 claims description 16
- 210000003456 pulmonary alveoli Anatomy 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 13
- 230000002631 hypothermal effect Effects 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 7
- 238000011065 in-situ storage Methods 0.000 claims description 7
- 238000004891 communication Methods 0.000 claims description 5
- 238000003780 insertion Methods 0.000 claims description 4
- 230000037431 insertion Effects 0.000 claims description 4
- 210000003734 kidney Anatomy 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- 230000002980 postoperative effect Effects 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims description 3
- 238000001356 surgical procedure Methods 0.000 claims description 3
- 208000000913 Kidney Calculi Diseases 0.000 claims description 2
- 206010029148 Nephrolithiasis Diseases 0.000 claims description 2
- 208000001130 gallstones Diseases 0.000 claims 1
- 238000007675 cardiac surgery Methods 0.000 abstract description 8
- 210000001519 tissue Anatomy 0.000 description 15
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- 206010061216 Infarction Diseases 0.000 description 6
- 208000015924 Lithiasis Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 230000007574 infarction Effects 0.000 description 6
- 210000004165 myocardium Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 208000037803 restenosis Diseases 0.000 description 5
- 208000031481 Pathologic Constriction Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000002872 contrast media Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 208000010125 myocardial infarction Diseases 0.000 description 4
- 230000036262 stenosis Effects 0.000 description 4
- 208000037804 stenosis Diseases 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 239000013543 active substance Substances 0.000 description 3
- 238000002399 angioplasty Methods 0.000 description 3
- 210000002376 aorta thoracic Anatomy 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000010410 reperfusion Effects 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 2
- 206010011086 Coronary artery occlusion Diseases 0.000 description 2
- 206010063837 Reperfusion injury Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 206010000891 acute myocardial infarction Diseases 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010007026 Calculus urethral Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010048964 Carotid artery occlusion Diseases 0.000 description 1
- 208000001778 Coronary Occlusion Diseases 0.000 description 1
- 206010016803 Fluid overload Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 102100031000 Hepatoma-derived growth factor Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001083798 Homo sapiens Hepatoma-derived growth factor Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 241000208202 Linaceae Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 108010016076 Octreotide Proteins 0.000 description 1
- 102000005157 Somatostatin Human genes 0.000 description 1
- 108010056088 Somatostatin Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000001101 cardioplegic effect Effects 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000003436 cytoskeletal effect Effects 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- APFVFJFRJDLVQX-AHCXROLUSA-N indium-111 Chemical compound [111In] APFVFJFRJDLVQX-AHCXROLUSA-N 0.000 description 1
- 229940055742 indium-111 Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- CPRSOZZDECJZKH-QRDGSJRXSA-F octasodium;[(2r,3r,4s,5r,6r)-2-[(2s,3s,4r,5r)-3,4-disulfonatooxy-2,5-bis(sulfonatooxymethyl)oxolan-2-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)oxan-4-yl] sulfate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]S(=O)(=O)O[C@H]1[C@H](OS([O-])(=O)=O)[C@@H](COS(=O)(=O)[O-])O[C@@]1(COS([O-])(=O)=O)O[C@@H]1[C@H](OS([O-])(=O)=O)[C@@H](OS([O-])(=O)=O)[C@H](OS([O-])(=O)=O)[C@@H](COS([O-])(=O)=O)O1 CPRSOZZDECJZKH-QRDGSJRXSA-F 0.000 description 1
- 229960002700 octreotide Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
- 229960000553 somatostatin Drugs 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008354 tissue degradation Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 150000005671 trienes Chemical class 0.000 description 1
- 201000009160 urethral calculus Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/104—Balloon catheters used for angioplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/1204—Type of occlusion temporary occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
- A61B5/6853—Catheters with a balloon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22001—Angioplasty, e.g. PCTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22038—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22067—Blocking; Occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22082—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22082—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
- A61B2017/22084—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance stone- or thrombus-dissolving
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2505/00—Evaluating, monitoring or diagnosing in the context of a particular type of medical care
- A61B2505/05—Surgical care
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
- A61M2025/09175—Guide wires having specific characteristics at the distal tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
Definitions
- Infusion catheter device for treating at least one partial or total obstruction in a conduit
- the invention relates to an infusion catheter device adapted to be introduced into a conduit, comprising at least one partial or total obstruction to be treated.
- the invention relates to an infusion catheter device which can be introduced into a channel of the body of an animal or a human being, which is selected from the group consisting of a blood vessel, a blood artery, a a coronary artery, the urinary tract, the esophagus and a pulmonary alveolus.
- the invention relates to a catheter device for cardiac surgery and interventional cardiology, in particular for treating coronary artery occlusion resulting in myocardial infarction with improved survival of the part of the heart muscle that depends on this. artery.
- this catheter device comprises a first conduit for the passage of a flexible guide wire 10, and a pressure detector element 12, presenting various possible embodiments, and according to the method Fig. 2 also provides a second infusion catheter delivery channel 32 for infusing a contrast fluid which can be used to position the guidewire 10 and the catheter device or a plurality of catheter devices.
- the pressure sensor can detect blood pressure and can be used in cooperation with other detectors to detect temperature, pH, and even Doppler detectors. It is pointed out that this device can be useful in a variety of applications including venous circuit, urinary tract and esophagus, see abstract, figures and claims.
- US Millar US 4,966,148 further discloses embodiments complementary to those described in the previous Millar US 4,771,782 of which this US Patent constitutes a continuation or CIP.
- infusion catheter comprising a central tube for passage of a guide wire allowing its introduction into the blood conduit consisting of a coronary catheter, said catheter comprising, towards its distal end, several lateral orifices at equal distance from each other at 3 cm from the end of the catheter, and an embodiment with four orifices placed between 0.5 cm and 1 cm from the distal end of the catheter.
- thermodilution catheter introduced into the coronary artery and introduced to near a stenosis in which the infusion catheter is advanced by sliding on a central guide wire provided at its distal end with a temperature sensor and introduced by a Y connector, leads Y1 (see Figure 1, page 2296), so that the The temperature sensor is disposed further downstream of the distal end of the catheter while the catheter has its distal end disposed proximal to the stenosis.
- an inflatable perivascular occlusion device is provided downstream of the distal end of the catheter.
- a second Y-connector is used to inject a saline solution into the infusion channel of the catheter at room temperature at a flow rate of 8 to 25 ml / min.
- the coronal pressure measurement and the temperature are retrieved on a Radi-analyzer interface and displayed.
- the pressure is measured at the distal end of the guide catheter and is recorded by regular pressure transducer and displayed on the interface.
- the achievements in humans were identical to those in dogs, except that the perivascular flow probe and the occlusion device were different.
- the catheter used had a distal end tapered or sloped so as to limit the flow of the nearest orifice among four orifices provided in the last 5 mm of the distal end of the infusion catheter.
- WO 2009/049823 REGITTNIG further describes a catheter comprising a first tubular element defining a first lumen and a first perforation, and a second tubular element defining a second lumen and a second perforation in which the second tubular element is configured to receive the first tubular element so as to define a chamber between the two and having an end of the second tubular element in contact with the end of the first tubular element.
- the first and second tubular members are arranged to provide a first fluid passage through the first perforation to a body under observation and a second fluid passage through the second perforation from the observation body and into the bedroom ; see Figures 1 to 10.
- the catheter comprises a fluid channel 82 defined between an inner tubular member 14 and an outer tubular member 12 for delivering an indicator fluid, as well as a channel for the guidewire 30 defined by the inner tubular member, one of the fluid infusion openings 40 being made at the distal end of the outer tubular member allowing the fluid to exit outside the catheter and into the blood conduit 80.
- the guide wire 30 comprises a temperature detector 32 positioned opposite an orifice 50 provided in the distal wall of the inner tubular element 14 to receive a flow of the fluid to measure its temperature ; see the figures and the abstract.
- WO 2012/164481 Discloses a system for measuring blood flow using an optical channel, in particular an optical fiber.
- Czygan et al. Discloses an implantable medical device having acoustic sensors for measuring mitral blood flow.
- This aortic catheter is to induce cardioplegic arrest to segment and selectively infuse the aorta during the cardiopulmonary bypass.
- a flow-by channel catheter which includes a guide wire deployment catheter called "over the wire", which is positioned just in below the artery having an occlusion according to a standard procedure.
- the flow-by channel then shunts the blood and thereby makes the atherostenotic plaque brittle, from high pressure carotid occlusion to the negative pressure end to effectively reverse the blood flow to through the obstructed or occluded artery.
- the stent is then advanced into the artery and deployed.
- the vascular catheter provides the benefit of collateral blood flow to solve the problem of stroke during endovascular procedures, see the abstract.
- the drug delivery ports are in the retracted position relative to the balloon when the balloon is in an expanded state and the outer balloon catheter must be retracted to expose the drug delivery ports for injection. drug.
- the structure of the device is different from the structure of the device according to the invention described hereinafter.
- MOHL US 8,177,704 discloses a catheter having an inflatable balloon 122 and orifices 129 downstream of the balloon 122.
- downstream orifices 129 are not used for the injection of any liquid but, on the contrary, for the detection of characteristics of the blood present downstream of the inflatable balloon, such as the blood pressure, the blood temperature, by the presence of detection devices. , which are located inside in a central lumen 125 (see Figures 4 and 5).
- EP 3,009,161 provides an intravascular micro-catheter for delivering active substances, such as drugs, which according to the first embodiment comprises pores regularly distributed in a high number of 20 to 200. at the distal or distal end of the catheter 3.
- an inflatable balloon 9 see Figures 4 and 5. It is stated that the balloon is designed to perform a proximal occlusion of the vessel, paragraph [0012], column 3, lines 29-31, in order to improve the efficiency of the delivery of the active substances to the destination only by preventing the return of the active substances, which is especially beneficial in the case of the use of toxic drugs, such as cytostatics, and the balloon also stabilizes the catheters, see column 3, lines 31-35.
- the balloon is not intended to have a function of treating the obstruction and this is a fundamental difference from the invention described hereinafter.
- US 2010/198186 also provides an inflatable balloon catheter and the possibility of injecting a fluid agent through the lumen, which serves as the guidewire, which fluid is in practice a contrast medium.
- the fluid flow orifices 310b are provided downstream of the balloon, see in particular Figure 5 and Figure 1, and the passage of column 4, lines 1 to 9, before paragraph [0041], see also paragraph [0049] on the embodiment of FIG. 5.
- the main object of the present invention is to solve the new technical problem consisting of the provision of a solution which makes it possible to treat at least one partial or total obstruction or occlusion in any conduit while being able to carry out a treatment of the wall of the conduit in which is the obstruction or occlusion and at least downstream thereof.
- Another object of the present invention is to solve this new technical problem according to a solution that makes it possible to deal with any type of partial or total obstruction in any conduit and in particular in a conduit constituted by a channel of the body of an animal or a human being which is selected from the group consisting of a blood vessel, a artery, a coronary artery, the urinary tract, the esophagus and a pulmonary alveolus, while being able to perform a treatment of the wall of the duct in which the obstruction or occlusion is located and at least downstream of the this one.
- Still another object of the invention is to solve the new technical problem of providing a solution of a catheter device for cardiac surgery, in particular for treating occlusion of a coronary artery resulting in myocardial infarction, with improvement of the survival of the part of the heart muscle that depends on this artery.
- the present invention also aims to solve these technical problems in a solution that is simple in construction, allowing easy manufacturing, reliable and reproducible on an industrial and medical scale.
- the invention relates to an infusion catheter device having a distal end and a proximal end, configured to be introduced into a conduit having an inner wall and an outer wall, comprising at least one obstruction or partial or total occlusion to be treated, said device comprising at its distal end on said outer wall one or more orifices for infusion of an infusion liquid, and upstream of the infusion orifice or orifices, proximal side of the catheter; infusion, on said outer wall at least one temporary closure shutter element configured to treat said obstruction or occlusion, movable between a non-sealing rest position and a shutter working position, and infusing the liquid of infusion downstream of the closure member in the closed position thereof.
- the invention relates to an infusion catheter device having a distal end and a proximal end, configured to be introduced into a conduit having an inner wall and an outer wall, comprising at least one partial obstruction or occlusion or total to be treated, said device comprising at its distal end on said outer wall one or more orifices for infusion of an infusion liquid, and upstream of the infusion orifice or ports, the proximal side of the infusion catheter, on said outer wall at least one temporary closure shutter element configured to treat said obstruction or occlusion, movable between a non-occluding rest position and a shutter working position,
- a conduit which is advantageously an animal body or human channel, which is selected from the group consisting of a blood vessel, a blood artery, a coronary artery, the urinary tract, the esophagus and a pulmonary alveolus and for simultaneously infusing the infusion liquid downstream of the closure element in the closed position of the this one.
- the invention also provides a method of treating a partial or total obstruction to be treated in a conduit having an inner wall and an outer wall, which conduit is a channel of the body of an animal or human being selected from the group consisting of a blood vessel, a blood artery, a coronary artery, urinary tract, esophagus and pulmonary alveolus,
- said method comprising the provision of a catheter device configured to be introduced into said duct, comprising at least one partial or total obstruction or occlusion to be treated, said device comprising at its distal end one or more infusion orifices of an infusion liquid, and upstream of the infusion port (s), proximal side of the infusion catheter, at least one temporary obturator shutter member configured to treat said obstruction or occlusion, movable between a non-operative rest position; shutter and a shutter work position, comprising:
- the guide wire is introduced through the catheter to have its distal end disposed downstream of the partial or total obstruction in said conduit; Or vice versa ;
- infusion of the infusion liquid either in said confined space or downstream of the obstruction or occlusion, through said infusion orifices, in order to ensure the treatment of said partial obstruction; or total present in said channel, the treatment of the walls of the conduit downstream of said obstruction or occlusion.
- the infusion liquid is a liquid brought to a temperature protecting the material or fabrics of the wall of the conduit.
- This temperature may be a temperature sufficiently cold to hibernate the tissues of the channel to be protected for a predetermined period of time.
- Those skilled in the art can determine the protective temperature of surrounding tissue downstream of the obstruction or occlusion.
- an infusion liquid brought to a temperature of 6 to 8 degrees Celsius lower than the temperature of the blood. during a period of 5 to 15 minutes, in particular of about 10 minutes.
- the temperature is measured by the presence of a temperature sensor located downstream of the infusion orifices, either on the catheter or on the guidewire. Under these conditions, the surrounding tissue temperature is about 3 to 6 ° C, especially about 4 ° C, lower than that of blood.
- a partial or total obstruction to be treated in any channel, in particular in a channel of the body of an animal or a human being, which may be selected from the constituent group of a vessel blood, a coronary artery, the urinary tract, the esophagus, a pulmonary alveolus, without limitation, while simultaneously treating the downstream canal wall to protect the material or the tissues constituting it .
- the invention relates to an infusion catheter device comprising an elongate substantially tubular shape defining a longitudinal axis, an outer surface and an inner surface and defining a distal end (D) and a proximal end (P), configured to be introduced into a conduit having an inner wall and an outer wall, comprising at least one partial or total obstruction or occlusion to be treated, said device comprising at its distal end (D) on said outer wall one or more infusion orifices infusion liquid (LI), and upstream of the infusion orifices, proximal side (P) of the infusion catheter, on said outer wall at least one temporary closure shutter element movable between a position non-occluding rest and a shutter working position configured to treat said obstruction or occlusion and infusing the infusion liquid (LI) downstream of the shutter member and in the closed position.
- an infusion catheter device comprising an elongate substantially tubular shape defining a longitudinal axis, an outer surface and an inner surface and defining a
- the device according to the invention is characterized in that said device comprises:
- a first substantially tubular member made of a flexible but substantially unexpandable material and substantially non-collapsible, configured to define a first channel for receiving a guidewire, and having an exit aperture at the distal end (D) of the device;
- a second element substantially tubular, made of a flexible but substantially unexpandable material and substantially non-collapsible, configured to define a second channel for receiving the infusion liquid LI, the one or more orifices (s) crossing through (s) ) the wall of the second element of the device for infusing, from the second channel, the infusion liquid LI outside the device.
- the diameter of the first channel and the second channel is substantially constant at least at the shutter member and in particular along the length of the catheter inside the conduit to be treated; and this diameter of each channel is independent of the rest position or occlusion of the shutter member.
- the diameter of the first channel may be different from the diameter of the second channel.
- the second channel is sealingly closed at the distal end in order to force the infusion liquid to pass through the infusion orifices.
- the first element is arranged coaxial with the catheter device.
- the second element may also be coaxial while having a diameter greater than the first element and thus being concentric and having its wall constituting the outer wall of the catheter device.
- the first element is disposed with its axis parallel to the longitudinal axis of the catheter device, in particular so as to have a wall common with the second element of the catheter device, while, according to a variant, the second member may constitute the outer wall of the catheter device, thereby defining the second channel between the second member and the first member.
- the device according to the invention is characterized in that the temporary closure element comprises an inflatable balloon disposed outside the catheter device and supplied with inflation fluid by an inflation channel arranged at the inside or the surface of the catheter, in particular the balloon inflation fluid may comprise a diluted contrast medium or not.
- a pressure differential is used: the super-compacting type balloon deploys from 5/6 bar for a maximum pressure of about 14/15 bar while that the second channel, or infusion duct, supports up to about 35/40 bars. It is therefore sufficient to increase the pressure of the infusion liquid to ensure the desired infusion rate.
- the catheter is connected to an automatic injection pump for programming the flow.
- the device according to the invention is characterized in that at least some infusion orifices are disposed on said outer wall at a distance from each other on the same axial plane of said catheter device.
- the device according to the invention is characterized in that at least some infusion orifices are disposed on said outer wall at a distance from each other on the same axis of said catheter device substantially parallel to the longitudinal axis of the device.
- the device according to the invention is characterized in that the guide wire comprises at least one or more temperature detector (s) of which at least one detector is positioned on a distal portion (D) of the guide wire for measuring the temperature of the infusion fluid, downstream of the aforementioned infusion orifices, distal side of the catheter device.
- the device according to the invention is characterized in that it comprises at least one or more temperature detector (s) of which at least one detector is positioned inside the catheter and in the vicinity of at least one infusion port, for measuring the temperature of the infusion fluid in situ prior to its exit through the aforementioned infusion ports, the distal side of the catheter device.
- the device according to the invention is characterized in that it comprises at least one so-called internal communication orifice with the chamber defined between the inner tubular element and the outer tubular element and in which circulates the infusion liquid LI, at least one of the said external infusion liquid LI infusion ports outside the catheter, for measuring the temperature of the infusion liquid, thanks to the presence of the wire guide provided with a temperature sensor element movable from the outside downstream to come in front of the internal orifice.
- the device according to the invention is characterized in that it comprises a channel C1 on the proximal side of infusion of the infusion liquid which may be a coolant introduced at a temperature below the temperature prevailing inside said conduit.
- the device according to the invention is characterized in that, when the obstruction or occlusion can be dissolved in a suitable liquid, such as for example a renal or biliary calculus, it comprises a channel C1 on the side proximal infusion of the infusion fluid which may be an infusion liquid comprising a product dissolving the obstruction or occlusion.
- a suitable liquid such as for example a renal or biliary calculus
- the solvents that can be used.
- a dissolving product of a calculation is, for example, ammonium chloride NH4Cl or ammonium nitrate NH4NO3.
- the device according to the invention is characterized in that it comprises a channel C1 on the proximal infusion side of the infusion liquid which may be a liquid comprising at least one drug for treating the tissues in the vicinity of the obstruction or occlusion.
- a drug for the inhibition of restenosis for example a polyionic derivative of cyclodextrin combined with a growth factor, in particular a heparin-binding growth factor, described in US Pat.
- a medicament for performing antithrombotic therapy or a cicatrization promoting medicament in an amount effective to induce a healing / healing response of injured tissue adjacent and downstream of the obstruction or occlusion, for example comprising or consisting of a non-reducing saccharide or a sulfated analogue thereof such as a non-reducing monosaccharide or disaccharide or a sulfated analogue thereof, for example glucose, sucrose, fructose, or a sulfated analogue thereof , in particular a solution of sodium sucrose octasulfate, described in WO 94/22885; a somatostatin type 1 receptor agonist substance as described in US 7,084,117; a NO precursor drug, for example selected from L-arginine, L-lysine, or mixtures thereof; another anti-restenosis agent may be selected from a drug inhibiting cell proliferation smooth muscle, a cytoskeletal inhibitor and
- This anti-restenosis agent may be water-soluble or non-water-soluble.
- a water-soluble anti-restenosis agent the latter may belong to the family of peptides whereas, as non-water-soluble drug, an example is a medicine belonging to the limus family.
- the device according to the invention is characterized in that the guidewire comprises at least one or more temperature detector (s) of which at least one detector is positioned on a distal portion of the guide to measure the infusion liquid temperature infused after said infusion ports, distal side of the catheter device, downstream or upstream of obstruction or occlusion in said conduit.
- the guidewire comprises at least one or more temperature detector (s) of which at least one detector is positioned on a distal portion of the guide to measure the infusion liquid temperature infused after said infusion ports, distal side of the catheter device, downstream or upstream of obstruction or occlusion in said conduit.
- the device according to the invention is characterized in that it comprises at least one or more temperature detector (s) of which at least one temperature detector is positioned inside the catheter and proximity of at least one infusion port, for measuring the temperature of the infusion liquid in situ prior to its exit through the aforesaid infusion ports, distal side of the catheter device.
- at least one or more temperature detector s of which at least one temperature detector is positioned inside the catheter and proximity of at least one infusion port, for measuring the temperature of the infusion liquid in situ prior to its exit through the aforesaid infusion ports, distal side of the catheter device.
- the device according to the invention is characterized in that it comprises at least one so-called internal communication orifice with the chamber defined between the internal tubular element and the external tubular element and in which circulates the infusion liquid, at the so-called external infusion holes of the liquid outside the catheter, for measuring the temperature of the infusion liquid by virtue of the presence of the guide wire provided with a temperature detector element that can be moved from the outside downstream until coming in front of the internal orifice.
- the device according to the invention is characterized in that it comprises at least one visual marking system at a proximal position, and / or at an intermediate position of the catheter device, and / or a distal position, allowing medical personnel to accurately locate the catheter device within the conduit to be treated.
- the device according to the invention is characterized in that the visual marking system comprises one or more radiopaque markers.
- the device according to the invention is designed to be introduced into the aforesaid conduit, which is a channel of the body of an animal or a human being, which is selected from the group consisting of a blood vessel , a blood artery, a coronary, the urinary tract, the esophagus and a pulmonary alveolus.
- the aforesaid conduit which is a channel of the body of an animal or a human being, which is selected from the group consisting of a blood vessel , a blood artery, a coronary, the urinary tract, the esophagus and a pulmonary alveolus.
- the invention relates to an infusion catheter device having a distal end and a proximal end, configured to be introduced into a conduit having an inner wall and an outer wall, comprising at least one obstruction. or partial or total occlusion to be treated, said device comprising at its distal end on said outer wall one or more infusion orifices for infusion liquid, and upstream of the infusion orifice or ports, on the proximal side of the catheter.
- a temporary closure shutter element configured to treat said obstruction or occlusion, movable between a non-occluding rest position and a shutter working position, to perform the treatment of at least a partial or total obstruction or occlusion present in a duct which is advantageously a channel of the body of an animal or a human being, which is hoisi among the group consisting of a blood vessel, a blood artery, a coronary artery, the urinary tract, the esophagus and a pulmonary alveolus and to simultaneously perform infusion of infusion liquid downstream of the closure member in the closed position thereof.
- the invention also relates to a method for treating at least one partial or total obstruction or occlusion present in a conduit, comprising:
- a catheter device into said conduit, said catheter device being as defined according to any embodiment defined for the first aspect described above or hereinafter, in particular equipped with a temperature detector at its distal end; this introduction being carried out while the operating device is in the rest position, until the shutter device is disposed in proximity, in particular within the obstruction or partial or total occlusion;
- the guide wire is introduced through the catheter to have its distal end disposed downstream of the partial or total obstruction in said conduit, or vice versa;
- infusion of the infusion liquid either in said confined space or downstream of the obstruction or occlusion, through said infusion orifices, in order to ensure either the treatment of said partial or total obstruction present in said channel, the treatment of the walls of the duct downstream of said obstruction or occlusion.
- this method provides for the use of a heat transfer infusion fluid set at a temperature to treat the walls of the conduit downstream of the obstruction or occlusion thermally.
- a heat transfer infusion fluid set at a temperature to treat the walls of the conduit downstream of the obstruction or occlusion thermally.
- the aforesaid conduit is a channel of the body of an animal or human, which is selected from the group consisting of a blood vessel, a blood artery, a coronary, the urinary tract, the esophagus and a pulmonary alveolus
- the temperature of the infusion liquid is adjusted to achieve hypothermia tissues of said body channel.
- the method of the invention comprises a surgical treatment by the insertion of a widening device at the level of the obstruction or occlusion, such as a stent, although known to those skilled in the art.
- this method also provides for a post-operative heat treatment by the catheter device according to the invention after achieving this enlargement at the level of the partial or total obstruction in said conduit, in order to improve the recovery. tissues of the body canal.
- an infusion liquid brought to a temperature of 6 to 8 degrees Celsius lower than the temperature of the blood. during a period of 5 to 15 minutes, in particular of about 10 minutes.
- the temperature is measured by the presence of a temperature sensor located downstream of the infusion orifices, either on the catheter or on the guidewire. Under these conditions, the surrounding tissue temperature is about 3 to 6 ° C, especially about 4 ° C, lower than that of blood.
- a partial or total obstruction to be treated in any channel, in particular in a channel of the body of an animal or a human being, which may be selected from the constituent group of a vessel blood, a coronary artery, the urinary tract, the esophagus, a pulmonary alveolus, without limitation, while treating the wall of the channel downstream to protect the material or the tissue constituting it.
- a thrombosis In the case of the body canal of an animal in the context of a blood vessel, a blood artery or a coronary artery, it is usually a thrombosis, a stenosis, or a a clot. In the urinary tract, it is usually for example a lithiasis or calculation.
- FIG. 1 diagrammatically shows a first embodiment of a catheter device according to the present invention provided with a closure element such as an inflation balloon upstream of the infusion orifices in the working position in FIG. a channel, such as a coronary artery shown in enlarged partial longitudinal axial section.
- a closure element such as an inflation balloon upstream of the infusion orifices in the working position in FIG. a channel, such as a coronary artery shown in enlarged partial longitudinal axial section.
- FIG. 2 represents a longitudinal axial sectional view of the device of FIG. 1, at the level of the obstruction or occlusion showing the closure element in working position, here crushing the obstruction or occlusion and showing the infusion of the infusion liquid downstream of the obstruction.
- FIG. 3 represents a view in transverse axial section along section line III - III of FIG. 2.
- FIG. 4 represents a view in transverse axial section along the cutting line IV - IV of FIG. 2.
- FIG. 5 is a diagrammatic view of a second embodiment of a catheter device according to the present invention provided with a closure member such as an inflation balloon.
- FIG. 6 shows an axial sectional view of the second catheter device according to the invention of Figure 5 with its shutter element in the so-called working position or inflated to better see the device.
- FIG. 7 represents a transverse axial sectional view along section line VII-VII of FIG. 5.
- FIG. 8 represents a view in transverse axial section along the cutting line VIII - VIII of FIG. 5.
- FIG. 9 represents a view in transverse axial section along the cutting line IX - IX of FIG. 5;
- FIG. 10 shows the second embodiment of FIGS. 5 to 9 of the catheter device according to the present invention in working position, arranged upstream of an obstruction or occlusion to be treated, here such as a calculation or lithiasis. bladder, kidney, or biliary.
- FIG. 11 shows an axial sectional view, similar to FIG. 2, of a third embodiment of a catheter device according to the present invention provided with a closure element such as an inflated inflation balloon. at the level and inside the obstruction to be treated.
- a closure element such as an inflated inflation balloon.
- FIG. 12 represents a transverse axial sectional view along section line XII-XII of FIG. 11.
- FIG. 13 represents a view in transverse axial section along the same section line XII-XII of FIG. 11, but in the retracted position of the guide wire with a temperature detection device facing a communication orifice with the central channel for the passage of the guide wire; and the FIG. 14 is an axial sectional view, similar to FIG. 2, of a fourth embodiment of a catheter device according to the present invention provided with a closure element such as an inflated inflation balloon. at and within the obstruction to be treated and including a first temperature sensor on the guidewire; and a second temperature sensor positioned within the infusion fluid passageway and in the vicinity of at least one infusion port for measuring the temperature of the infusion fluid in situ prior to exit through the orifices. infusion, distal side of the catheter device.
- a closure element such as an inflated inflation balloon
- FIGS. 1 to 4 there is shown a first embodiment of a catheter device having the general reference numeral 10, configured to be introduced into a conduit having an inner wall and an outer wall, comprising at least a partial or total obstruction or occlusion to be treated, said device 10 comprises an elongated substantially tubular shape defining a proximal end P and a distal end D, a longitudinal axis XX and having a substantially tubular outer wall 12 defining an outer surface 13 and a internal surface 14.
- said device 10 also comprises at its distal end (D), on said outer wall 12, one or more orifices 16, 18, 20, 22 for infusion of an infusion liquid (LI), and upstream of the infusion port (s), proximal (P) side of the infusion catheter, on said outer wall 12, at least one shutter element 70 temporarily closed to treat said obstruction or occlusion and simultaneously carry out the infusion infusion liquid (LI) downstream of the shutter member, and in the closed position thereof.
- the device according to the invention is characterized in that said device comprises:
- a substantially tubular first member 28 made of a flexible but substantially unexpandable and substantially non-collapsible material configured to define a first channel 29 for receiving a guidewire 30, and having an outlet opening 29a at the distal end (D) the device;
- a second substantially tubular member made of a flexible but substantially unexpandable and substantially non-collapsible material configured to define a second channel 14 for receiving the infusion liquid LI; the one or more orifices (16, 18, 20, 22) for infusion passing through the wall of the second element (12) of the device for infusing, from the second channel, the infusion liquid LI to the outside the device.
- the second channel is closed at its distal end by a sealed partition 12c in order to force the infusion liquid LI to pass through the infusion orifices 16, 18, 20 , 22.
- the first element 28 is disposed coaxially with the catheter device 10.
- the second element 12 can also be coaxial while having a larger diameter. large than the first element 28, thus being concentric and with its wall which constitutes the outer wall of the catheter device.
- the device according to the invention is characterized in that the temporary shutter element 70 comprises an inflatable balloon 72 disposed outside the catheter device and supplied with inflation fluid via a channel 80.
- inflating device disposed inside or on the surface of the catheter 10, having a lumen 82 opening into the internal space 74 of the balloon 72 by a
- the inflation fluid of the balloon such as a gas, for example air, or a liquid, may comprise a non-diluted contrast medium.
- a pressure differential is used: the super-compacting type balloon deploys from 5/6 bar for a maximum pressure of about 14/15 bar while that the second channel, or infusion duct, supports up to about 35/40 bars. It is therefore sufficient to increase the pressure of the infusion liquid to ensure the desired infusion rate.
- the catheter is connected to an automatic injection pump not shown here to program the flow.
- the device according to the invention is characterized in that it comprises at least one temperature detector 32 positioned towards the distal end D of the catheter device, said temperature detector 32 being positioned to measure a temperature of the infusion liquid LI outside said catheter device in the vicinity of the aforementioned infusion orifices 16, 18, 20, 22.
- the device according to the invention is characterized in that at least some infusion orifices 16, 18, 20, 22 are arranged, on said outer wall, at a distance from each other on the same axial plane of said catheter device, as shown in Figure 4.
- the device according to the invention is characterized in that the infusion liquid is a coolant introduced at a temperature below the temperature inside said conduit.
- the device according to the invention is characterized in that, when the obstruction or occlusion can be dissolved in a suitable liquid, such as for example a kidney or biliary calculus, the infusion fluid is an infusion liquid comprising a product dissolving the obstruction or occlusion.
- a suitable liquid such as for example a kidney or biliary calculus
- the infusion fluid is an infusion liquid comprising a product dissolving the obstruction or occlusion.
- a suitable liquid such as for example a kidney or biliary calculus
- the infusion fluid is an infusion liquid comprising a product dissolving the obstruction or occlusion.
- a dissolving product of a calculation is, for example, ammonium chloride NH4Cl or ammonium nitrate NH4NO3.
- the device according to the invention is characterized in that the infusion liquid is a liquid comprising at least one drug for treating the tissues in the vicinity of the obstruction or occlusion.
- the infusion liquid is a liquid comprising at least one drug for treating the tissues in the vicinity of the obstruction or occlusion.
- drugs for example, a medicament chosen from the list given above.
- the device according to the invention is characterized in that the guidewire 30 comprises at least one or more temperature detector (s) 32, at least one detector 32 of which is positioned on a distal portion of the guide for measuring the temperature of the infusion liquid infused after the aforesaid infusion ports, distal side of the catheter device, downstream of the obstruction or occlusion in said conduit, as shown in Figures 1 and 2.
- s temperature detector
- the device according to the invention is characterized in that it comprises at least one visual marking system at a proximal position, and / or at an intermediate position of the catheter device, and / or at a distal position, allowing medical personnel to accurately locate the catheter device within the conduit to be treated.
- the device according to the invention is characterized in that the visual marking system comprises one or more radiopaque markers provided at the positions making it possible to precisely locate at least the position of the end distal of the catheter device, the infusion orifices and the obturator element.
- the device according to the invention is characterized in that the aforesaid conduit 50 is a channel of the body of an animal or a human being, which is selected from the group consisting of a blood vessel, a a blood artery, a coronary artery, the urinary tract, the esophagus and a pulmonary alveolus.
- FIGS. 1 A second embodiment is shown in FIGS.
- the catheter carries the general reference numeral 110, the guide wire 130 and the temperature detector that it carries 132, the shutter element 170, such as a balloon 172, powered by a dedicated channel 180 defining a light 182 and opening into the interior space 174 of the balloon 172 through an opening 184.
- the first element 128 is disposed with its axis parallel to the longitudinal axis XX of the catheter device 110, in particular so as to have a wall 128a common with the second tubular element 112 also defining the outer wall here.
- the second channel 114 may be defined by the space existing between the second tubular element 112 and the first tubular element 128.
- the second channel 114 is closed at its distal end by a sealed partition 114c to force the infusion liquid to pass through the infusion orifices 116, 118, 122.
- the device according to the invention is characterized in that at least some brewing orifices 116, 118, 122 are arranged at a distance from one another on the same axis of said catheter device substantially parallel to the longitudinal axis of the device, as shown in Figure 9.
- This second embodiment of the infusion orifices is naturally possible with the first embodiment of Figures 1 to 4, and vice versa.
- a third embodiment is shown in Figures 11 to 13, wherein the parts having the same function have the same reference numbers as in the two previous embodiments, but further increased by 100.
- the catheter here carries the general reference No. 210, the guidewire 230 and the temperature sensor that carries 232, the shutter member 270, such as a balloon 272, powered by a dedicated channel 280 defining a lumen 282 and opening into the inner space 274 of the balloon 272 through an opening 284.
- the device according to the invention is characterized in that it comprises at least one internal orifice 236 passing through the wall of the internal tubular element 228 to make a communication of the first channel 129 with the second channel
- the catheter here carries the general reference number 310, the guide wire 330 and the temperature sensor that it carries 332, the shutter element 370, such as a balloon 372, powered by a dedicated channel 380 defining a lumen 382 and opening into the interior space 374 of the balloon 372 through an opening 384.
- the device according to the invention is characterized in that it comprises at least one or more temperature detector (s) 332, 342, of which at least one temperature detector 342 is positioned at the inside the catheter, here in the second channel 314 and in the vicinity of at least one infusion port 320, for measuring the temperature of the infusion fluid in situ before its exit through the aforementioned infusion orifices, the distal side of the catheter device.
- s temperature detector
- the guide wire carrying the temperature detector 332 disposed outside the catheter can remain in a relatively fixed position without having to be retracted as in the third embodiment of FIGS. 11 to 13. Measurement of the temperature of the LI infusion liquid takes place simultaneously in situ inside the catheter before its infusion and outside after its infusion into the channel 350.
- the invention provides an infusion catheter device (10; 110) having a distal end (D) and a proximal end (P) configured to be introduced into a conduit (50; 150) having a inner wall (54; 154) and an outer wall (56; 156) comprising at least one obstruction (60; 160) or partial or total occlusion to be treated, said device comprising at its end distal (D) on said outer surface one or more orifices (16; 116, 18; 118, 20, 22; 122) for infusion of an infusion liquid (LI), and upstream of the at least one orifices; infusing, proximal (P) the infusion catheter (10; 110), on said outer surface at least one shutter member (70) provisionally configured to treat said obstruction (60) or occlusion and perform the infusion infusion liquid (LI) downstream of the shutter member (70) and in the closed position, for performing the treatment of at least one partial or total obstruction or occlusion present in a duct which is advantageously a
- the invention also relates to a method of treating at least one partial or total obstruction or occlusion present in a conduit, applicable to the four embodiments of the catheter device described above, comprising:
- a catheter device into said conduit, said catheter device being as defined in any embodiment defined for the first aspect described above or hereinafter, in particular equipped with a catheter detector; temperature at its distal end; this introduction being carried out while the shutter device is in the rest position, until the shutter device is disposed close to, in particular within the obstruction or partial or total occlusion as shown in FIGS. at 4, and 11 to 14, or upstream of the obstruction as shown in the embodiment of Figures 5 to 10; b) the guidewire is introduced through the catheter to have its distal end disposed downstream of the partial or total obstruction in said conduit;
- steps a) and b) can be reversed.
- this method provides for the use of a heat transfer infusion fluid set at a temperature to treat the walls of the conduit downstream of the obstruction or occlusion thermally.
- the aforesaid conduit is a channel of the body of an animal or human, which is selected from the group consisting of a blood vessel, a blood artery, a coronary, the urinary tract, the esophagus and a pulmonary alveolus
- the temperature of the infusion liquid is adjusted to achieve hypothermia tissues of said body channel.
- the method of the invention comprises a surgical treatment by inserting an enlargement device at the obstruction or occlusion, such as a stent, well known to those skilled in the art.
- this method also provides for a post-operative heat treatment by the catheter device according to the invention after achieving this enlargement at the level of the partial or total obstruction in said conduit, in order to improve the recovery. tissues of the body canal.
- the object of the invention is to achieve selective hypothermia, thus selectively cool the portion of the heart muscle at risk in patients with acute myocardial infarction.
- This cooling (hypothermia) must begin a few minutes (about 10 minutes) before the occluded artery - and therefore responsible for the infarction - is recanalized (reopened).
- This cooling should continue for a few minutes (10 minutes) again after the recanalization of the artery.
- hypothermia makes it possible to limit the size of the infarctions and thus, to improve the prognosis of the patients.
- the advantage of the method of selective hypothermia according to the invention is to very quickly reach the desired temperature, to cool only the portion of the heart muscle at risk and that the volume overload is very reduced. As a result, little or no systemic effects are to be feared.
- the catheter according to the invention combines the characteristics of a conventional balloon catheter and an infusion catheter, has dimensions very similar to those of a conventional balloon catheter. It can therefore be constructed in the following way.
- the catheter generally has three channels or lights: either a first channel or light 29; 229, or 329, coaxial, shown in Figures 1 to 4, and 11 to 14, a first lateral channel 128, said monorail, defining a first lateral lumen, shown in Figures 5 to 10, which allows the catheter to be advanced on any guide wire 30, 130, 230, 330 of 0.014 inches, and therefore also on a guide wire 30, 130, 230, 330, provided with a sensor 32, 132, 232, 332, and / or pressure, or vice versa;
- This inflation of the balloon can be performed from the LC channel proximally by insufflation of a gas or a liquid which can if desired include a diluted contrast medium which allows the exact position of the catheter to be verified. and in particular the balloon with respect to obstruction or occlusion as well as infusion orifices.
- the inflation and deflation of the balloon is carried out in the same way as for conventional balloons.
- a pressure differential to ensure the passage of the infusion liquid with the inflated balloon is used a pressure differential:
- the super-compact type of balloon deploys from 5/6 bar for a maximum pressure of about 14/15 bars while the second channel, or infusion duct, supports up to about 35/40 bars. It is therefore sufficient to increase the pressure of the infusion liquid to ensure the desired infusion rate while the balloon is inflated.
- the catheter is connected to an automatic injection pump not shown here to program the flow.
- the catheter may have a length of about 20 to 22 cm, may have an outer diameter of less than one mm, for example 0.95 mm.
- the infusion orifices may for example have a diameter of about 150 micrometers and be located 7 to 8 mm from the distal end of the catheter and be positioned at 0 °, 180 °, and / or 90 ° and 270 ° therefore diametrically opposed and / or axially offset along the axis of the catheter as shown in the four embodiments of Figures 1 to 14.
- the proximal end of the catheter is thus provided with two connectors.
- the first allows to connect a infusion liquid infusion pump LI and the second C2 to connect a syringe or inflation pump or deflation of the balloon 72, 172, 272, 372.
- the patient who has an acute myocardial infarction and needs to undergo primary angioplasty, is installed on the catheterization table exactly as usual.
- the carrier catheter 10, 110, 210, 310 is advanced femorally or radially.
- This guide wire is advanced in the distal part of the artery, through the occlusion responsible for the infarction.
- the catheter 10, 110, 210, 310 is connected to the infusion pump and the tubings are rinsed with any air bubbles.
- the catheter is then mounted on the guide wire 30, 130, 230, 330 and the balloon 72, 172, 272, 372 is advanced at the coronary occlusion 60, 160, 260 or 360.
- the balloon 72, 172, 272, 372 is immediately inflated at this level to avoid reperfusion of the infarcted segment.
- infusion liquid LI for example sterilized physiological fluid which can be heparinized at the temperature of The desired heat treatment, starting for example at the temperature of the operating chamber, is then started. This infusion during balloon occlusion is maintained for 10 minutes.
- the distal temperature is monitored by at least one temperature detector or thermistor 32, 132, 232, 332, 342 located in the distal portion of the artery.
- the temperature in the distal portion of the coronary artery should be about 6 to 8 degrees lower than the blood temperature. Under these conditions, a temperature of the myocardial tissues close to 4 degrees lower than that of the blood was obtained.
- the infusion liquid for example physiological liquid
- infusion liquid for example physiological liquid
- infusion liquid for example physiological liquid
- the temperature of the mixture is controlled by the thermistor located in the distal portion of the artery. This temperature should be 4 to 5 degrees below the temperature of the blood. It is known that, under these conditions, the temperature of the adjacent myocardium is about 4 degrees below the temperature of the blood.
- the catheter 10, 110, 210, 310 according to the invention is removed and a stent is placed with another suitable catheter according to the local routine.
- the duration of infusion and the temperature of the infused liquid are variable. Therefore, the method according to the invention is also valid for other brewing times and other temperatures.
- the catheter is described with either 4 lateral ports in FIGS. 1 to 4, and 11 to 14, or with 3 lateral ports in FIGS. 5 to 10 in the same axial plane, and an orifice distal but other combinations are of course conceivable, with also a distribution of orifices along an axis parallel to the longitudinal axis of the device, as shown in Figures 5 to 10.
- the catheter according to the invention can be used with other guidewires and the insertion procedure can be reversed.
- the catheter according to the invention is therefore a combination of an infusion catheter and a balloon catheter.
- the purpose of this combination is to simultaneously allow the occlusion of the vessel and the infusion of an infusion liquid to perform a treatment of tissues arranged after the occlusion according to the embodiment of Figures 1 to 4, and 11 at 14, a dissolution of the occlusion according to the embodiment of Figures 5 to 10, as shown below.
- Example 5 By following a procedure similar to that described for Example 5 but by arranging the infusion orifices before the obstruction or occlusion such as a computation or lithiasis disposed in the urinary tract, it is possible after inflation of the balloon 172, to infuse a liquid of destruction or dissolution of the occlusion for a period of time necessary and under usual supervision.
- the obstruction or occlusion such as a computation or lithiasis disposed in the urinary tract
- the second channel 114 can be opened at its distal end to allow the infusion liquid to pass not only through the infusion ports 116, 118, 122 but also through the distal opening of the second channel.
- This variant is applicable to the four embodiments of Figures 1 to 14.
- the catheter device according to the invention is therefore very versatile and can be used to perform the treatment of different types of obstruction or occlusion in different types of ducts as previously described.
- FIGS. 1 to 14 form an integral part of the invention and complete the description of the invention.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Thermal Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Surgical Instruments (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17731243.6A EP3463542A1 (fr) | 2016-06-01 | 2017-05-31 | Dispositif formant catheter d'infusion pour traiter au moins une obstruction partielle ou totale dans un conduit, tel que conduit corporel |
EA201892481A EA201892481A1 (ru) | 2016-06-01 | 2017-05-31 | Инфузионный катетер для лечебного воздействия по меньшей мере на одну частичную или полную обструкцию в канале тела |
CA3026309A CA3026309A1 (fr) | 2016-06-01 | 2017-05-31 | Dispositif formant catheter d'infusion pour traiter au moins une obstruction partielle ou totale dans un conduit, tel que conduit corporel |
JP2018563176A JP7051719B2 (ja) | 2016-06-01 | 2017-05-31 | 体の通路などの通路で阻害の少なくとも一部または全体を治療するための注入カテーテルを形成する装置 |
KR1020187038223A KR102417729B1 (ko) | 2016-06-01 | 2017-05-31 | 신체 통로와 같은 통로 내의 적어도 하나의 부분적인 또는 전체적인 폐쇄물을 치료하기 위한 주입 카테터를 형성하는 디바이스 |
US16/306,288 US11602618B2 (en) | 2016-06-01 | 2017-05-31 | Device forming an infusion catheter for treating at least one partial or total obstruction in a passage, such as a body passage |
JP2022001690A JP7372992B2 (ja) | 2016-06-01 | 2022-01-07 | 体の通路などの通路で阻害の少なくとも一部または全体を治療するための注入カテーテルを形成する装置 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1654974A FR3052075B1 (fr) | 2016-06-01 | 2016-06-01 | Dispositif formant catheter d'infusion pour traiter au moins une obstruction partielle ou totale dans un conduit, tel que conduit corporel |
FR1654974 | 2016-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017207931A1 true WO2017207931A1 (fr) | 2017-12-07 |
Family
ID=56990525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2017/051368 WO2017207931A1 (fr) | 2016-06-01 | 2017-05-31 | Dispositif formant catheter d'infusion pour traiter au moins une obstruction partielle ou totale dans un conduit, tel que conduit corporel |
Country Status (8)
Country | Link |
---|---|
US (1) | US11602618B2 (fr) |
EP (1) | EP3463542A1 (fr) |
JP (2) | JP7051719B2 (fr) |
KR (1) | KR102417729B1 (fr) |
CA (1) | CA3026309A1 (fr) |
EA (1) | EA201892481A1 (fr) |
FR (1) | FR3052075B1 (fr) |
WO (1) | WO2017207931A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108378898A (zh) * | 2018-04-11 | 2018-08-10 | 深圳盛航科技有限公司 | 一种肾结石溶除装置及溶除方法 |
WO2020178401A1 (fr) * | 2019-03-06 | 2020-09-10 | Ubitemp | Dispositif pour le traitement d'un infarctus du myocarde |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111870289B (zh) * | 2020-08-21 | 2023-02-07 | 南阳市中心医院 | 一种呼吸科气管镜介入治疗装置 |
Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4771782A (en) | 1986-11-14 | 1988-09-20 | Millar Instruments, Inc. | Method and assembly for introducing multiple catheters into a biological vessel |
US4966148A (en) | 1986-11-14 | 1990-10-30 | Millar Instruments, Inc. | Assembly for positioning diagnostic devices in a biological vessel |
WO1994022885A1 (fr) | 1993-03-29 | 1994-10-13 | Queen's University At Kingston | Composes anticoagulants |
US5415636A (en) | 1994-04-13 | 1995-05-16 | Schneider (Usa) Inc | Dilation-drug delivery catheter |
US5874419A (en) | 1989-04-23 | 1999-02-23 | The Trustees Of The University Of Pennsylvania | Compositions and methods for modulating growth of a tissue in a mammal |
US6585689B1 (en) | 1997-12-08 | 2003-07-01 | Cardeon Corporation | Aortic catheter and methods for inducing cardioplegic arrest and for selective aortic perfusion |
US6689097B2 (en) | 2000-02-09 | 2004-02-10 | Jeffrey J. Thramann | Flow-by channel catheter and method of use |
US20050113798A1 (en) | 2000-07-21 | 2005-05-26 | Slater Charles R. | Methods and apparatus for treating the interior of a blood vessel |
US20050239743A1 (en) | 2004-04-12 | 2005-10-27 | Pro-Pharmaceuticals, Inc. | Compositions and methods to inhibit restenosis |
US7084117B2 (en) | 2001-01-12 | 2006-08-01 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
EP1930045A1 (fr) | 2006-12-08 | 2008-06-11 | BIOTRONIK CRM Patent AG | Système médical implantable avec un capteur acoustique pour la mesure du débit sanguin mitral |
US20090018498A1 (en) | 2003-03-12 | 2009-01-15 | Abbott Cardiovascular Systems Inc. | Infusion treatment agents, catheters, filter devices, and occlusion devices, and use thereof |
WO2009049823A1 (fr) | 2007-10-16 | 2009-04-23 | Werner Regittnig | Cathéter et procédés pour l'utiliser et le fabriquer |
US20100198186A1 (en) | 2009-02-03 | 2010-08-05 | Ackermann Simon | Dual-lumen catheter for medical device delivery systems |
US8177704B1 (en) | 2011-12-22 | 2012-05-15 | Miracor Medical Systems Gmbh | System and method for treating heart tissue |
WO2012164481A1 (fr) | 2011-06-01 | 2012-12-06 | Koninklijke Philips Electronics N.V. | Système de débitmétrie sanguine répartie |
US20140323887A1 (en) | 2013-04-25 | 2014-10-30 | Boston Scientific Scimed, Inc. | Thermodilution catheter systems and methods for determining blood flow rates |
EP3009161A1 (fr) | 2014-10-15 | 2016-04-20 | Innovations for Heart and Vessels Sp. z o.o. | Microcathéter intravasculaire d'administration de substances actives |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5328471A (en) * | 1990-02-26 | 1994-07-12 | Endoluminal Therapeutics, Inc. | Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens |
US5037392A (en) * | 1989-06-06 | 1991-08-06 | Cordis Corporation | Stent-implanting balloon assembly |
AU7313391A (en) * | 1990-02-20 | 1991-09-18 | Regents Of The University Of California, The | Apparatus, catheter and method for chemical contact dissolution of gallstones |
US6620188B1 (en) * | 1998-08-24 | 2003-09-16 | Radiant Medical, Inc. | Methods and apparatus for regional and whole body temperature modification |
US5569197A (en) * | 1994-12-21 | 1996-10-29 | Schneider (Usa) Inc | Drug delivery guidewire |
JPH09117510A (ja) * | 1995-10-26 | 1997-05-06 | Buaayu:Kk | インフュージョンカテーテル |
US6295990B1 (en) | 1998-02-03 | 2001-10-02 | Salient Interventional Systems, Inc. | Methods and systems for treating ischemia |
EP1251899B1 (fr) | 2000-02-04 | 2012-04-25 | CONMED Endoscopic Technologies, Inc. | Catheter a ballonnet et a trois lumieres destine a l'elimination de calculs |
US20030013986A1 (en) * | 2001-07-12 | 2003-01-16 | Vahid Saadat | Device for sensing temperature profile of a hollow body organ |
US20040167467A1 (en) | 2003-02-21 | 2004-08-26 | Kent Harrison | Delivering cooled fluid to sites inside the body |
US8266030B2 (en) | 2009-09-15 | 2012-09-11 | Chicago Mercantile Exchange Inc. | Transformation of a multi-leg security definition for calculation of implied orders in an electronic trading system |
US8267887B2 (en) | 2010-05-26 | 2012-09-18 | Miracor Medical Systems Gmbh | Treating heart tissue |
US10315016B2 (en) * | 2016-01-04 | 2019-06-11 | Corflow Therapeutics Ag | System and methods for treating MVO |
-
2016
- 2016-06-01 FR FR1654974A patent/FR3052075B1/fr active Active
-
2017
- 2017-05-31 EA EA201892481A patent/EA201892481A1/ru unknown
- 2017-05-31 CA CA3026309A patent/CA3026309A1/fr active Pending
- 2017-05-31 EP EP17731243.6A patent/EP3463542A1/fr active Pending
- 2017-05-31 WO PCT/FR2017/051368 patent/WO2017207931A1/fr unknown
- 2017-05-31 US US16/306,288 patent/US11602618B2/en active Active
- 2017-05-31 KR KR1020187038223A patent/KR102417729B1/ko active IP Right Grant
- 2017-05-31 JP JP2018563176A patent/JP7051719B2/ja active Active
-
2022
- 2022-01-07 JP JP2022001690A patent/JP7372992B2/ja active Active
Patent Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4966148A (en) | 1986-11-14 | 1990-10-30 | Millar Instruments, Inc. | Assembly for positioning diagnostic devices in a biological vessel |
US4771782A (en) | 1986-11-14 | 1988-09-20 | Millar Instruments, Inc. | Method and assembly for introducing multiple catheters into a biological vessel |
US5874419A (en) | 1989-04-23 | 1999-02-23 | The Trustees Of The University Of Pennsylvania | Compositions and methods for modulating growth of a tissue in a mammal |
WO1994022885A1 (fr) | 1993-03-29 | 1994-10-13 | Queen's University At Kingston | Composes anticoagulants |
US5415636A (en) | 1994-04-13 | 1995-05-16 | Schneider (Usa) Inc | Dilation-drug delivery catheter |
US6585689B1 (en) | 1997-12-08 | 2003-07-01 | Cardeon Corporation | Aortic catheter and methods for inducing cardioplegic arrest and for selective aortic perfusion |
US6689097B2 (en) | 2000-02-09 | 2004-02-10 | Jeffrey J. Thramann | Flow-by channel catheter and method of use |
US20050113798A1 (en) | 2000-07-21 | 2005-05-26 | Slater Charles R. | Methods and apparatus for treating the interior of a blood vessel |
US7084117B2 (en) | 2001-01-12 | 2006-08-01 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
US20090018498A1 (en) | 2003-03-12 | 2009-01-15 | Abbott Cardiovascular Systems Inc. | Infusion treatment agents, catheters, filter devices, and occlusion devices, and use thereof |
US20050239743A1 (en) | 2004-04-12 | 2005-10-27 | Pro-Pharmaceuticals, Inc. | Compositions and methods to inhibit restenosis |
EP1930045A1 (fr) | 2006-12-08 | 2008-06-11 | BIOTRONIK CRM Patent AG | Système médical implantable avec un capteur acoustique pour la mesure du débit sanguin mitral |
WO2009049823A1 (fr) | 2007-10-16 | 2009-04-23 | Werner Regittnig | Cathéter et procédés pour l'utiliser et le fabriquer |
US20100198186A1 (en) | 2009-02-03 | 2010-08-05 | Ackermann Simon | Dual-lumen catheter for medical device delivery systems |
WO2012164481A1 (fr) | 2011-06-01 | 2012-12-06 | Koninklijke Philips Electronics N.V. | Système de débitmétrie sanguine répartie |
US8177704B1 (en) | 2011-12-22 | 2012-05-15 | Miracor Medical Systems Gmbh | System and method for treating heart tissue |
US20140323887A1 (en) | 2013-04-25 | 2014-10-30 | Boston Scientific Scimed, Inc. | Thermodilution catheter systems and methods for determining blood flow rates |
EP3009161A1 (fr) | 2014-10-15 | 2016-04-20 | Innovations for Heart and Vessels Sp. z o.o. | Microcathéter intravasculaire d'administration de substances actives |
Non-Patent Citations (3)
Title |
---|
AARNOUDSE; MM PIJLS; DE BRUYNE ET AL., JOURNAL OF AMERICAN COLLEGE OF CARDIOLOGY, vol. 50, no. 24, 2007, pages 2214 - 2304 |
MR. CAMENZIND ET AL., JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, vol. 43, no. l, January 2004 (2004-01-01) |
VAN'T VEER; MONSIEUR PIJLS ET AL., MEDICAL ENGINEERING ET PHYSICS, vol. 31, 2009, pages 688 - 694 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108378898A (zh) * | 2018-04-11 | 2018-08-10 | 深圳盛航科技有限公司 | 一种肾结石溶除装置及溶除方法 |
WO2020178401A1 (fr) * | 2019-03-06 | 2020-09-10 | Ubitemp | Dispositif pour le traitement d'un infarctus du myocarde |
FR3093423A1 (fr) * | 2019-03-06 | 2020-09-11 | Ubitemp | Dispositif pour le traitement d’un infarctus du myocarde. |
Also Published As
Publication number | Publication date |
---|---|
FR3052075B1 (fr) | 2022-01-07 |
EA201892481A1 (ru) | 2019-05-31 |
JP7372992B2 (ja) | 2023-11-01 |
US11602618B2 (en) | 2023-03-14 |
JP7051719B2 (ja) | 2022-04-11 |
FR3052075A1 (fr) | 2017-12-08 |
JP2019520127A (ja) | 2019-07-18 |
CA3026309A1 (fr) | 2017-12-07 |
EP3463542A1 (fr) | 2019-04-10 |
JP2022033355A (ja) | 2022-02-28 |
US20190290889A1 (en) | 2019-09-26 |
KR102417729B1 (ko) | 2022-07-07 |
KR20190015730A (ko) | 2019-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6044845A (en) | Methods and systems for treating ischemia | |
EP1289596B1 (fr) | Systeme de protection contre l'embolisation pour interventions vasculaires | |
US20190046760A1 (en) | Microvascular obstruction detection and therapy | |
US5833658A (en) | Catheters for the delivery of solutions and suspensions | |
US5167628A (en) | Aortic balloon catheter assembly for indirect infusion of the coronary arteries | |
US5891108A (en) | Drug delivery stent | |
JP7372992B2 (ja) | 体の通路などの通路で阻害の少なくとも一部または全体を治療するための注入カテーテルを形成する装置 | |
US20020169436A1 (en) | Percutaneous method of preventing distal embolisation while maintaining adequate distal perfusion in percutaneous interventional procedures | |
JP2013500142A (ja) | 流れ配向鞘付きフラッシュカテーテル | |
US20080097339A1 (en) | Catheter with filtering and sensing elements | |
US20050273049A1 (en) | Drug delivery device using microprojections | |
BRPI0709062A2 (pt) | aparelho para administrar um tratamento médico | |
US8303538B2 (en) | Rheolytic thrombectomy catheter with self-inflating distal balloon | |
CA2509288A1 (fr) | Methode d'administration de medicaments dans l'adventice au moyen d'un dispositif muni de micropointes | |
EP3409316B1 (fr) | Dispositif d angioplastie | |
JP2007501654A (ja) | 再狭窄鎮静装置および方法 | |
JP2013526960A (ja) | 組織注入装置及び方法 | |
EP2584979A1 (fr) | Canule pour la réalisation d'une circulation extracorporelle régionale | |
ES2942559T3 (es) | Sistema para limpieza de coágulos para reinserción | |
JP2010279713A (ja) | 挿入カテーテルをロックして消毒するための装置およびキット | |
JPH11164890A (ja) | ダブルバルーン型カテーテル | |
WO2000041763A9 (fr) | Appareil et procede d'administration localisee d'un medicament dans un tissu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17731243 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2018563176 Country of ref document: JP Kind code of ref document: A Ref document number: 3026309 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20187038223 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2017731243 Country of ref document: EP Effective date: 20190102 |